Stefan G Sarafianos

Emory University

NIH Rank #1948
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$3.6M
Fiscal year 2024
Grants Awarded
9
Active NIH grants
National Rank
#1,948
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.6M across 9 grants · National rank #1948.

Top grants by award amount

Stefan G Sarafianos's NIH grant portfolio, ranked by award amount.

  • 1R01AI177696-01A1R01
    Discovery of Antivirals Targeting Mpox Virus
    $782.1K
    award amount
  • 5R01AI167356-03R01
    Discovery of SARS-CoV-2 antivirals using a replicon assay
    $678.7K
    award amount
  • 5U54AI170855-03U54
    Behavior of HIV in Viral Environments (B-HIVE)
    $585.5K
    award amount
  • 5R01AI120860-10R01
    Development of HIV capsid-targeting antivirals that affect immune response by modulating capsid stability and have improved resistance profiles
    $530.5K
    award amount
  • 5R37AI076119-16R37
    Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIV
    $470.9K
    award amount
  • 3U54AI170855-03S1U54
    Experimental characterization and computational modeling of intrinsic bioreactivity of SuFEx/covalent nucleophile warheads
    $253.4K
    award amount
  • 5R21AI176946-02R21
    Affinity Gradient-Based Transport of HIV Capsid Cores through the Nuclear Pore Complex
    $195.6K
    award amount
  • 3R01AI167356-03S1R01
    Discovery of SARS-CoV-2 antivirals using a replicon assay
    $75.3K
    award amount
  • 3R01AI167356-02S1R01
    Discovery of SARS-CoV-2 antivirals using a replicon assay
    $14K
    award amount

Affiliations

Institutions that have administered grants for Stefan G Sarafianos.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Emory University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1948
  6. 2024
    Entered Top 25% Nationally
    Ranked #1948
  7. 2024
    Entered Top 10% Nationally
    Ranked #1948
  8. 2024
    Multi-Institutional Research
    Awards at 2 institutions